Bromide

Bromide

SCHEMBL574337

Br.CCCCCCN1C=CN(Cc2ccccc2)C1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 2/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C19 P33261 2/20 0.45
KCNH2 Q12809 1/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
DRD3 P35462 1/20 0.41
HSD17B10 Q99714 1/20 0.41
EEF2K O00418 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5284664 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL5302624 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL5286590 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL5301218 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL5817323 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL5297855 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL5307711 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL5295981 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL5302861 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL5288974 0.98 ALDH1A1 (0.47) ALDH1A1LMNACYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9999217-B2 Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures BIOMATRICA, INC. (US) 2018-06-19 US claimed
EP-2598660-B1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES BIOMATRICA INC (US) 2017-03-15 EP claimed
US-20160338342-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES EXACT SCIENCES CORPORATION 2016-11-24 US claimed
US-9376709-B2 Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures BIOMATRICA, INC. (US) 2016-06-28 US claimed
EP-2598660-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES Biomatrica, INC. (US) 2013-06-05 EP claimed
US-20120052572-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES EXACT SCIENCES CORPORATION 2012-03-01 US claimed
WO-2012018638-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES BIOMATRICA, INC. (US) 2012-02-09 WO claimed
US-20220032306-A1 CAPSULE CONTAINMENT OF DRIED REAGENTS TALIS BIOMEDICAL CORPORATION 2022-02-03 US disclosed
US-20210008559-A1 CAPSULE CONTAINMENT OF DRIED REAGENTS TALIS BIOMEDICAL CORPORATION 2021-01-14 US disclosed
US-10207269-B2 System and method for movement and timing control CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-02-19 US disclosed
EP-2839260-B1 FLUIDIC DEVICES AND SYSTEMS FOR SAMPLE PREPARATION OR AUTONOMOUS ANALYSIS TALIS BIOMEDICAL CORP (US) 2018-07-18 EP disclosed
US-9999217-B2 Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures BIOMATRICA, INC. (US) 2018-06-19 US disclosed
US-9822356-B2 Fluidic devices and systems for sample preparation or autonomous analysis CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-11-21 US disclosed
US-20130309679-A1 FLUIDIC DEVICES AND SYSTEMS FOR SAMPLE PREPARATION OR AUTONOMOUS ANALYSIS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2013-11-21 US disclosed
WO-2013159117-A1 FLUIDIC DEVICES AND SYSTEMS FOR SAMPLE PREPARATION OR AUTONOMOUS ANALYSIS SlipChip, LLC (US) 2013-10-24 WO disclosed
WO-2013159116-A1 FLUIDIC DEVICES FOR BIOSPECIMEN PRESERVATION UNIVERSITY OF CHICAGO (US) 2013-10-24 WO disclosed
US-20130280725-A1 FLUIDIC DEVICES FOR BIOSPECIMEN PRESERVATION CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2013-10-24 US disclosed
EP-2598660-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES Biomatrica, INC. (US) 2013-06-05 EP disclosed
US-20120052572-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES EXACT SCIENCES CORPORATION 2012-03-01 US disclosed
WO-2012018638-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES BIOMATRICA, INC. (US) 2012-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160338342-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES HNRNPD, HNRNPDL, HNRNPL ALDH1A1 3155/4885LMNA 542/4885CYP1A2 4597/4885
US-20120052572-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES HNRNPD, HNRNPDL, HNRNPL ALDH1A1 3155/4885LMNA 542/4885CYP1A2 4597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.